Home › Stocks › ABCL › All Fund Holders
ABCL — ABCELLERA BIOLOGICS INC · All Fund Holders
Funds holding (latest): 45 · Reported value held: $479.31M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Capital World Investors history | Q2 2026 | 13.59M | $106.67M | 0.01% | Add |
| Two Sigma Investments history | Q2 2026 | 10.44M | $81.93M | 0.06% | Reduce |
| Baillie Gifford & Co history | Q3 2025 | 10.42M | $52.43M | 0.04% | Add |
| Bank of America Corp history | Q2 2026 | 6.14M | $48.21M | 0.00% | Add |
| Harvard Management Company history | Q1 2023 | 4.11M | $30.95M | 3.30% | Hold |
| BlackRock Inc history | Q2 2026 | 3.81M | $29.87M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 2.75M | $21.58M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 2.07M | $16.25M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 1.90M | $14.93M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 1.67M | $13.10M | 0.00% | Reduce |
| Casdin Capital history | Q1 2024 | 2.36M | $10.69M | 0.80% | Hold |
| Arrowstreet Capital history | Q2 2026 | 1.04M | $8.16M | 0.00% | New |
| Renaissance Technologies history | Q2 2026 | 990.93K | $7.78M | 0.01% | Reduce |
| BNY Mellon history | Q1 2023 | 787.98K | $5.94M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 518.57K | $4.07M | 0.00% | Reduce |
| Point72 Asset Management history | Q1 2026 | 1.15M | $4.01M | 0.01% | Add |
| Charles Schwab Investment Management history | Q1 2023 | 472.39K | $3.56M | 0.00% | Add |
| Temasek Holdings history | Q2 2022 | 281.73K | $3.00M | 0.02% | New |
| Geode Capital Management history | Q2 2026 | 315.72K | $2.48M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 298.62K | $2.34M | 0.00% | Add |
| Balyasny Asset Management history | Q3 2025 | 404.40K | $2.03M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 235.13K | $1.85M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2023 | 194.03K | $1.25M | 0.00% | Reduce |
| Lazard Asset Management history | Q1 2026 | 305.22K | $1.07M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2025 | 176.39K | $603.24K | 0.00% | Reduce |
| Manulife Financial history | Q1 2023 | 76.08K | $573.66K | 0.00% | Hold |
| Wells Fargo & Co history | Q2 2026 | 60.34K | $473.63K | 0.00% | Add |
| MFS Investment Management history | Q4 2022 | 46.02K | $466.14K | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 49.75K | $390.56K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 45.43K | $356.63K | 0.00% | New |
| Polen Capital Management history | Q4 2025 | 102.51K | $350.58K | 0.00% | Reduce |
| AQR Capital Management history | Q4 2022 | 32.91K | $333.41K | 0.00% | New |
| Maverick Capital history | Q2 2023 | 48.05K | $310.42K | 0.01% | Reduce |
| CPP Investments history | Q3 2022 | 31.29K | $310.00K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q1 2023 | 27.04K | $203.80K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 21.85K | $177.43K | 0.00% | New |
| Principal Global Investors history | Q1 2024 | 34.20K | $154.94K | 0.00% | Reduce |
| Amundi US history | Q3 2023 | 26.57K | $113.17K | 0.00% | Hold |
| Prudential Financial history | Q1 2023 | 13.23K | $99.75K | 0.00% | Hold |
| Vanguard Group history | Q4 2023 | 13.11K | $74.87K | 0.00% | New |
| Fidelity International (FIL) history | Q4 2024 | 24.06K | $70.50K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 7.18K | $56.38K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 1.59M | $12.46K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q3 2024 | 750 | $1.95K | 0.00% | New |
| PNC Financial Services history | Q2 2024 | 200 | $592 | 0.00% | Hold |